Clinical Trials Directory

Trials / Completed

CompletedNCT04111328

the Effect of Different Drugs and Infusion Ways on Degree of Postoperative Comfort

the Effect of Different Drugs and Infusion Ways on Degree of Comfort for Patients Undergoing Spinal Neoplasm Surgery

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
600 (actual)
Sponsor
Jun Wang · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

To explore the effect of different drugs and infusion ways on degree of postoperative comfort.Patients undergoing spinal neoplasm surgery receive different patient controlled analgesia(PCA) drugs postoperatively,one group is sufentanil,the other is hydromorphone. Then each drug group will be divided into two subgroups according to the infusion way,intravenously,subcutaneously. During the patient controlled analgesia period, patients' degree of comfort,pain score,sleep quality, the degree of side reaction will be recorded.

Conditions

Interventions

TypeNameDescription
DRUGintravenous sufentanilThe PCA pumps contain sufentanil . And the pump is connected to participants intravenously .
DRUGsubcutaneous sufentanilThe PCA pumps contain sufentanil. And the pump is connected to participants subcutaneously.
DRUGintravenous hydromorphoneThe PCA pumps contain hydromorphone. And the pump is connected to participants intravenously .
DRUGsubcutaneous hydromorphoneThe PCA pumps contain hydromorphone. And the pump is connected to participants subcutaneously.
DRUGintravenous sufentanil and dexmedetomidineThe PCA pumps contain sufentanil and dexmedetomidine. And the pump is connected to participants intravenously .
DRUGsubcutaneous sufentanil and dexmedetomidineThe PCA pumps contain sufentanil and dexmedetomidine. And the pump is connected to participants subcutaneously.
DRUGintravenous hydromorphone and dexmedetomidineThe PCA pumps contain hydromorphone and dexmedetomidine. And the pump is connected to participants intravenously.
DRUGsubcutaneous hydromorphone and dexmedetomidineThe PCA pumps contain hydromorphone and dexmedetomidine. And the pump is connected to participants subcutaneously

Timeline

Start date
2019-10-08
Primary completion
2020-09-30
Completion
2020-10-30
First posted
2019-10-01
Last updated
2021-02-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04111328. Inclusion in this directory is not an endorsement.